Taking aim at disease

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus
ORNL radioisotope manufacturing coordinator Jillene Sennon-Greene places a shipment vial of actinium-225 inside the dose calibrator to confirm its activity is within customer specifications. (Photo: Carlos Jones/ORNL, DOE)

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.

That tiny amount of the radioisotope was purchased by the hospital for use in cancer studies. And it heralded a new peacetime mission for ORNL, built just a few years earlier for the production of plutonium from uranium for the Manhattan Project.

To continue reading, log in or create a free account!

Related Articles

Centrus to expand Oak Ridge facility

January 26, 2026, 9:38AMNuclear News

Centrus Energy Corp. is planning a major expansion of its Oak Ridge, Tenn., Technology and Manufacturing Center. The build-out would allow it to expedite large-scale deployment of...

Congress passes new nuclear funding

January 20, 2026, 3:37PMNuclear News

On January 15, in an 82–14 vote, the U.S. Senate passed an Energy and Water Development appropriations bill to fund the U.S. Department of Energy for fiscal year 2026 as part of a broader...